When administering codeine for cough suppression, what is a priority finding to monitor for?

When administering codeine for cough suppression, the priority finding to monitor for is agitation. Codeine is an opioid, which can impact central nervous system function. While it is often used to suppress cough due to its analgesic and sedative properties, it can also lead to respiratory depression, particularly in sensitive individuals or those with preexisting respiratory conditions.

Agitation can signal adverse effects such as withdrawal symptoms or the potential for increased CNS depression, which could lead to confusion or altered mental status due to the drug's sedative effects. This makes monitoring for agitation particularly vital, as it can indicate a need for immediate intervention to ensure patient safety.

In contrast, although constipation is a known side effect of opioids and may also be monitored, it is generally considered a less immediate concern compared to the potential acute effects on the central nervous system, such as agitation or respiratory depression. Elevated blood pressure and hyperactivity are not common side effects associated with codeine; the medication is more likely to cause sedation rather than stimulation or cardiovascular changes. Thus, being vigilant for indicators of agitation is paramount in ensuring safe administration of codeine for cough suppression.